Embolism from the heart or the thoracic aorta often leads to clinically significant morbidity
and mortality due to transient ischemic attack, stroke or occlusion of peripheral arteries …

Long-term survival rates after a diagnosis of breast cancer are steadily rising. This is good
news, but clinicians must also recognize that this brings new challenges to the medical …

Background: The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is
unknown. Objectives: This study investigated the long-term prognosis of patients with …

Background A fixed-dose regimen of rivaroxaban, an oral factor Xa inhibitor, has been
shown to be as effective as standard anticoagulant therapy for the treatment of deep-vein …

Document Reviewers: Jose-Luis Zamorano,(CPG Review Coordinator)(Spain), Felicita
Andreotti (Italy), Michael Ascherman (Czech Republic), George Athanassopoulos (Greece) …

Objective Implementation of machine learning (ML) may be limited by patients' right to
“meaningful information about the logic involved” when ML influences healthcare decisions …

A small proportion of patients with deep vein thrombosis develop recurrent venous
thromboembolic complications or bleeding during anticoagulant treatment. These …

Background Chronic thromboembolic pulmonary hypertension (CTPH) is associated with
considerable morbidity and mortality. Its incidence after pulmonary embolism and …

We have previously demonstrated that a clinical model can be safely used in a management
strategy in patients with suspected pulmonary embolism (PE). We sought to simplify the …

Background Little is known about the prognosis of cancer discovered during or after an
episode of venous thromboembolism. Methods We linked the Danish National Registry of …